Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Rajagopal L, Masse BW, Huang M, Oyamada Y, Meltzer HY
The tendon receives limited blood flow, which slows healing
Study Design Type: Phase 2, double-blind, randomized, placebo-controlled study Participants: 338 adults (BMI 30 or BMI 27 with a coexisting condition) Groups: Retatrutide 1 mg, 4 mg, 8 mg, 12 mg (different initial doses 2 or 4 mg) and placebo Duration: 48 weeks (plus 4 weeks follow-up) Administration: subcutaneous, 1x weekly Primary endpoint: percentage change in body weight at week 24 Secondary endpoints: change in weight at week 48, 5%, 10%, 15% weight reduction
Rimlig dos och vrde fr pengarna Doser och priser varierar kraftigt
Kono Y, Iizuka H, Isokawa M, Tsunoda M, Ichiba H, Sadamoto K, et al
US$ 26.00
US$ 21.32
US$ 24.38
US$ 26.50
